A compilation of documented data from 45 Africa malaria-endemic countries on the scale-up of malaria diagnostics and treatment
October 2010Read up-to-date articles highlighting our activities in 2009 and the financial statement for that year.
May 2010
The continued funding of malaria drug R&D is critical in the fight against...
MMV and Malawi Ministry of Health sow the seeds for a fruitful collaboration.
The Global Fund is looking for experts to serve on its Technical Review Panel. The experts must have sound technical knowledge and extensive program experience in HIV/AIDS, TB or malaria.
MMV’s Director, Global Access, Ambrose Talisuna, has been profiled in The Lancet as a powerful advocate for access to effective antimalarial treatments.
MMV's Statement for World Malaria Day
MMV will contribute intellectual property to the Pool for Open Innovation Against Neglected Tropical Diseases.
MMV and Ferrer, one of Spain’s major pharmaceutical groups, have agreed to explore the Ferrer compound library for promising molecules that could be developed into novel medicines needed to defeat malaria.
Through access to AstraZeneca’s extensive compound library, MMV will seek to identify promising compounds with the potential to treat malaria.
If you would like to contact the media office, please contact Jaya Banerji, Director, Advocacy & Communications.
Tel: +41 (0) 22 799 4071
Mobile: +41 (0) 79 707 7181
Email: banerjij [at] mmv [dot] org
